Sofinnova Partners strengthens crossover investing team with Roche Venture’s David Evans

European life sciences VC investor Sofinnova Partners has appointed former Roche Venture Fund senior investment director David Evans as a partner, strengthening its late-stage investment capabilities as the firm continues to expand its crossover investing strategy.